Global Lung Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Lung Cancer Diagnostics market size was valued at US$ 1842.5 million in 2023. With growing demand in downstream market, the Lung Cancer Diagnostics is forecast to a readjusted size of US$ 2748.9 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Lung Cancer Diagnostics market. Lung Cancer Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lung Cancer Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lung Cancer Diagnostics market.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Lung Cancer Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lung Cancer Diagnostics market. It may include historical data, market segmentation by Type (e.g., Immunoassays, Flow Cytometry), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lung Cancer Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lung Cancer Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lung Cancer Diagnostics industry. This include advancements in Lung Cancer Diagnostics technology, Lung Cancer Diagnostics new entrants, Lung Cancer Diagnostics new investment, and other innovations that are shaping the future of Lung Cancer Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lung Cancer Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Lung Cancer Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lung Cancer Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lung Cancer Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lung Cancer Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lung Cancer Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lung Cancer Diagnostics market.
Market Segmentation:
Lung Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Lung Cancer Diagnostics market size was valued at US$ 1842.5 million in 2023. With growing demand in downstream market, the Lung Cancer Diagnostics is forecast to a readjusted size of US$ 2748.9 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Lung Cancer Diagnostics market. Lung Cancer Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lung Cancer Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lung Cancer Diagnostics market.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Lung Cancer Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lung Cancer Diagnostics market. It may include historical data, market segmentation by Type (e.g., Immunoassays, Flow Cytometry), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lung Cancer Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lung Cancer Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lung Cancer Diagnostics industry. This include advancements in Lung Cancer Diagnostics technology, Lung Cancer Diagnostics new entrants, Lung Cancer Diagnostics new investment, and other innovations that are shaping the future of Lung Cancer Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lung Cancer Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Lung Cancer Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lung Cancer Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lung Cancer Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lung Cancer Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lung Cancer Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lung Cancer Diagnostics market.
Market Segmentation:
Lung Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Immunoassays
- Flow Cytometry
- Rapid Tests
- Molecular Assays
- Tissue Arrays
- Circulating Tumor Cells
- Pharmacodiagnostics
- Biomarkers
- Other
- Industrial
- Healthcare
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Diagnostics
- BioMйrieux
- Qiagen
- Advpharma
- AIT Austrian Institute of Technology
- Courtagen Life Sciences
- DiagnoCure
- BioMark Diagnostics
- Mayo Clinic
- HalioDx SAS
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Cancer Diagnostics Market Size 2019-2030
2.1.2 Lung Cancer Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lung Cancer Diagnostics Segment by Type
2.2.1 Immunoassays
2.2.2 Flow Cytometry
2.2.3 Rapid Tests
2.2.4 Molecular Assays
2.2.5 Tissue Arrays
2.2.6 Circulating Tumor Cells
2.2.7 Pharmacodiagnostics
2.2.8 Biomarkers
2.2.9 Other
2.3 Lung Cancer Diagnostics Market Size by Type
2.3.1 Lung Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Lung Cancer Diagnostics Segment by Application
2.4.1 Industrial
2.4.2 Healthcare
2.4.3 Other
2.5 Lung Cancer Diagnostics Market Size by Application
2.5.1 Lung Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
3 LUNG CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Lung Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Lung Cancer Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTICS BY REGIONS
4.1 Lung Cancer Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Lung Cancer Diagnostics Market Size Growth (2019-2024)
4.3 APAC Lung Cancer Diagnostics Market Size Growth (2019-2024)
4.4 Europe Lung Cancer Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Lung Cancer Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Lung Cancer Diagnostics Market Size by Country (2019-2024)
5.2 Americas Lung Cancer Diagnostics Market Size by Type (2019-2024)
5.3 Americas Lung Cancer Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Diagnostics Market Size by Region (2019-2024)
6.2 APAC Lung Cancer Diagnostics Market Size by Type (2019-2024)
6.3 APAC Lung Cancer Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lung Cancer Diagnostics by Country (2019-2024)
7.2 Europe Lung Cancer Diagnostics Market Size by Type (2019-2024)
7.3 Europe Lung Cancer Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Cancer Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LUNG CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Lung Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Lung Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Lung Cancer Diagnostics Forecast
10.1.3 APAC Lung Cancer Diagnostics Forecast
10.1.4 Europe Lung Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Lung Cancer Diagnostics Forecast
10.2 Americas Lung Cancer Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Lung Cancer Diagnostics Market Forecast
10.2.2 Canada Lung Cancer Diagnostics Market Forecast
10.2.3 Mexico Lung Cancer Diagnostics Market Forecast
10.2.4 Brazil Lung Cancer Diagnostics Market Forecast
10.3 APAC Lung Cancer Diagnostics Forecast by Region (2025-2030)
10.3.1 China Lung Cancer Diagnostics Market Forecast
10.3.2 Japan Lung Cancer Diagnostics Market Forecast
10.3.3 Korea Lung Cancer Diagnostics Market Forecast
10.3.4 Southeast Asia Lung Cancer Diagnostics Market Forecast
10.3.5 India Lung Cancer Diagnostics Market Forecast
10.3.6 Australia Lung Cancer Diagnostics Market Forecast
10.4 Europe Lung Cancer Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Lung Cancer Diagnostics Market Forecast
10.4.2 France Lung Cancer Diagnostics Market Forecast
10.4.3 UK Lung Cancer Diagnostics Market Forecast
10.4.4 Italy Lung Cancer Diagnostics Market Forecast
10.4.5 Russia Lung Cancer Diagnostics Market Forecast
10.5 Middle East & Africa Lung Cancer Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Lung Cancer Diagnostics Market Forecast
10.5.2 South Africa Lung Cancer Diagnostics Market Forecast
10.5.3 Israel Lung Cancer Diagnostics Market Forecast
10.5.4 Turkey Lung Cancer Diagnostics Market Forecast
10.5.5 GCC Countries Lung Cancer Diagnostics Market Forecast
10.6 Global Lung Cancer Diagnostics Forecast by Type (2025-2030)
10.7 Global Lung Cancer Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Lung Cancer Diagnostics Product Offered
11.1.3 Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 BioMйrieux
11.2.1 BioMйrieux Company Information
11.2.2 BioMйrieux Lung Cancer Diagnostics Product Offered
11.2.3 BioMйrieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioMйrieux Main Business Overview
11.2.5 BioMйrieux Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Lung Cancer Diagnostics Product Offered
11.3.3 Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 Advpharma
11.4.1 Advpharma Company Information
11.4.2 Advpharma Lung Cancer Diagnostics Product Offered
11.4.3 Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Advpharma Main Business Overview
11.4.5 Advpharma Latest Developments
11.5 AIT Austrian Institute of Technology
11.5.1 AIT Austrian Institute of Technology Company Information
11.5.2 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Offered
11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AIT Austrian Institute of Technology Main Business Overview
11.5.5 AIT Austrian Institute of Technology Latest Developments
11.6 Courtagen Life Sciences
11.6.1 Courtagen Life Sciences Company Information
11.6.2 Courtagen Life Sciences Lung Cancer Diagnostics Product Offered
11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Courtagen Life Sciences Main Business Overview
11.6.5 Courtagen Life Sciences Latest Developments
11.7 DiagnoCure
11.7.1 DiagnoCure Company Information
11.7.2 DiagnoCure Lung Cancer Diagnostics Product Offered
11.7.3 DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DiagnoCure Main Business Overview
11.7.5 DiagnoCure Latest Developments
11.8 BioMark Diagnostics
11.8.1 BioMark Diagnostics Company Information
11.8.2 BioMark Diagnostics Lung Cancer Diagnostics Product Offered
11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioMark Diagnostics Main Business Overview
11.8.5 BioMark Diagnostics Latest Developments
11.9 Mayo Clinic
11.9.1 Mayo Clinic Company Information
11.9.2 Mayo Clinic Lung Cancer Diagnostics Product Offered
11.9.3 Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mayo Clinic Main Business Overview
11.9.5 Mayo Clinic Latest Developments
11.10 HalioDx SAS
11.10.1 HalioDx SAS Company Information
11.10.2 HalioDx SAS Lung Cancer Diagnostics Product Offered
11.10.3 HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 HalioDx SAS Main Business Overview
11.10.5 HalioDx SAS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Cancer Diagnostics Market Size 2019-2030
2.1.2 Lung Cancer Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lung Cancer Diagnostics Segment by Type
2.2.1 Immunoassays
2.2.2 Flow Cytometry
2.2.3 Rapid Tests
2.2.4 Molecular Assays
2.2.5 Tissue Arrays
2.2.6 Circulating Tumor Cells
2.2.7 Pharmacodiagnostics
2.2.8 Biomarkers
2.2.9 Other
2.3 Lung Cancer Diagnostics Market Size by Type
2.3.1 Lung Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Lung Cancer Diagnostics Segment by Application
2.4.1 Industrial
2.4.2 Healthcare
2.4.3 Other
2.5 Lung Cancer Diagnostics Market Size by Application
2.5.1 Lung Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
3 LUNG CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Lung Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Lung Cancer Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTICS BY REGIONS
4.1 Lung Cancer Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Lung Cancer Diagnostics Market Size Growth (2019-2024)
4.3 APAC Lung Cancer Diagnostics Market Size Growth (2019-2024)
4.4 Europe Lung Cancer Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Lung Cancer Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Lung Cancer Diagnostics Market Size by Country (2019-2024)
5.2 Americas Lung Cancer Diagnostics Market Size by Type (2019-2024)
5.3 Americas Lung Cancer Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Diagnostics Market Size by Region (2019-2024)
6.2 APAC Lung Cancer Diagnostics Market Size by Type (2019-2024)
6.3 APAC Lung Cancer Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lung Cancer Diagnostics by Country (2019-2024)
7.2 Europe Lung Cancer Diagnostics Market Size by Type (2019-2024)
7.3 Europe Lung Cancer Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Cancer Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LUNG CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Lung Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Lung Cancer Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Lung Cancer Diagnostics Forecast
10.1.3 APAC Lung Cancer Diagnostics Forecast
10.1.4 Europe Lung Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Lung Cancer Diagnostics Forecast
10.2 Americas Lung Cancer Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Lung Cancer Diagnostics Market Forecast
10.2.2 Canada Lung Cancer Diagnostics Market Forecast
10.2.3 Mexico Lung Cancer Diagnostics Market Forecast
10.2.4 Brazil Lung Cancer Diagnostics Market Forecast
10.3 APAC Lung Cancer Diagnostics Forecast by Region (2025-2030)
10.3.1 China Lung Cancer Diagnostics Market Forecast
10.3.2 Japan Lung Cancer Diagnostics Market Forecast
10.3.3 Korea Lung Cancer Diagnostics Market Forecast
10.3.4 Southeast Asia Lung Cancer Diagnostics Market Forecast
10.3.5 India Lung Cancer Diagnostics Market Forecast
10.3.6 Australia Lung Cancer Diagnostics Market Forecast
10.4 Europe Lung Cancer Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Lung Cancer Diagnostics Market Forecast
10.4.2 France Lung Cancer Diagnostics Market Forecast
10.4.3 UK Lung Cancer Diagnostics Market Forecast
10.4.4 Italy Lung Cancer Diagnostics Market Forecast
10.4.5 Russia Lung Cancer Diagnostics Market Forecast
10.5 Middle East & Africa Lung Cancer Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Lung Cancer Diagnostics Market Forecast
10.5.2 South Africa Lung Cancer Diagnostics Market Forecast
10.5.3 Israel Lung Cancer Diagnostics Market Forecast
10.5.4 Turkey Lung Cancer Diagnostics Market Forecast
10.5.5 GCC Countries Lung Cancer Diagnostics Market Forecast
10.6 Global Lung Cancer Diagnostics Forecast by Type (2025-2030)
10.7 Global Lung Cancer Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Lung Cancer Diagnostics Product Offered
11.1.3 Roche Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 BioMйrieux
11.2.1 BioMйrieux Company Information
11.2.2 BioMйrieux Lung Cancer Diagnostics Product Offered
11.2.3 BioMйrieux Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioMйrieux Main Business Overview
11.2.5 BioMйrieux Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Lung Cancer Diagnostics Product Offered
11.3.3 Qiagen Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 Advpharma
11.4.1 Advpharma Company Information
11.4.2 Advpharma Lung Cancer Diagnostics Product Offered
11.4.3 Advpharma Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Advpharma Main Business Overview
11.4.5 Advpharma Latest Developments
11.5 AIT Austrian Institute of Technology
11.5.1 AIT Austrian Institute of Technology Company Information
11.5.2 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Offered
11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AIT Austrian Institute of Technology Main Business Overview
11.5.5 AIT Austrian Institute of Technology Latest Developments
11.6 Courtagen Life Sciences
11.6.1 Courtagen Life Sciences Company Information
11.6.2 Courtagen Life Sciences Lung Cancer Diagnostics Product Offered
11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Courtagen Life Sciences Main Business Overview
11.6.5 Courtagen Life Sciences Latest Developments
11.7 DiagnoCure
11.7.1 DiagnoCure Company Information
11.7.2 DiagnoCure Lung Cancer Diagnostics Product Offered
11.7.3 DiagnoCure Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DiagnoCure Main Business Overview
11.7.5 DiagnoCure Latest Developments
11.8 BioMark Diagnostics
11.8.1 BioMark Diagnostics Company Information
11.8.2 BioMark Diagnostics Lung Cancer Diagnostics Product Offered
11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioMark Diagnostics Main Business Overview
11.8.5 BioMark Diagnostics Latest Developments
11.9 Mayo Clinic
11.9.1 Mayo Clinic Company Information
11.9.2 Mayo Clinic Lung Cancer Diagnostics Product Offered
11.9.3 Mayo Clinic Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mayo Clinic Main Business Overview
11.9.5 Mayo Clinic Latest Developments
11.10 HalioDx SAS
11.10.1 HalioDx SAS Company Information
11.10.2 HalioDx SAS Lung Cancer Diagnostics Product Offered
11.10.3 HalioDx SAS Lung Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 HalioDx SAS Main Business Overview
11.10.5 HalioDx SAS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lung Cancer Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immunoassays
Table 3. Major Players of Flow Cytometry
Table 4. Major Players of Rapid Tests
Table 5. Major Players of Molecular Assays
Table 6. Major Players of Tissue Arrays
Table 7. Major Players of Circulating Tumor Cells
Table 8. Major Players of Pharmacodiagnostics
Table 9. Major Players of Biomarkers
Table 10. Major Players of Other
Table 11. Lung Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 13. Global Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 14. Lung Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 15. Global Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 16. Global Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 17. Global Lung Cancer Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 18. Global Lung Cancer Diagnostics Revenue Market Share by Player (2019-2024)
Table 19. Lung Cancer Diagnostics Key Players Head office and Products Offered
Table 20. Lung Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Lung Cancer Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 24. Global Lung Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Table 25. Global Lung Cancer Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Lung Cancer Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Lung Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 28. Americas Lung Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 29. Americas Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. Americas Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. Americas Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. Americas Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. APAC Lung Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 34. APAC Lung Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 35. APAC Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. APAC Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. APAC Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. APAC Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Europe Lung Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 40. Europe Lung Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 41. Europe Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Europe Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Europe Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Europe Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Middle East & Africa Lung Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 47. Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 49. Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 50. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 51. Key Market Drivers & Growth Opportunities of Lung Cancer Diagnostics
Table 52. Key Market Challenges & Risks of Lung Cancer Diagnostics
Table 53. Key Industry Trends of Lung Cancer Diagnostics
Table 54. Global Lung Cancer Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 55. Global Lung Cancer Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 56. Global Lung Cancer Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 57. Global Lung Cancer Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 58. Roche Diagnostics Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 59. Roche Diagnostics Lung Cancer Diagnostics Product Offered
Table 60. Roche Diagnostics Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Roche Diagnostics Main Business
Table 62. Roche Diagnostics Latest Developments
Table 63. BioMйrieux Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 64. BioMйrieux Lung Cancer Diagnostics Product Offered
Table 65. BioMйrieux Main Business
Table 66. BioMйrieux Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. BioMйrieux Latest Developments
Table 68. Qiagen Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 69. Qiagen Lung Cancer Diagnostics Product Offered
Table 70. Qiagen Main Business
Table 71. Qiagen Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Qiagen Latest Developments
Table 73. Advpharma Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 74. Advpharma Lung Cancer Diagnostics Product Offered
Table 75. Advpharma Main Business
Table 76. Advpharma Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Advpharma Latest Developments
Table 78. AIT Austrian Institute of Technology Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 79. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Offered
Table 80. AIT Austrian Institute of Technology Main Business
Table 81. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. AIT Austrian Institute of Technology Latest Developments
Table 83. Courtagen Life Sciences Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 84. Courtagen Life Sciences Lung Cancer Diagnostics Product Offered
Table 85. Courtagen Life Sciences Main Business
Table 86. Courtagen Life Sciences Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Courtagen Life Sciences Latest Developments
Table 88. DiagnoCure Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 89. DiagnoCure Lung Cancer Diagnostics Product Offered
Table 90. DiagnoCure Main Business
Table 91. DiagnoCure Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. DiagnoCure Latest Developments
Table 93. BioMark Diagnostics Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 94. BioMark Diagnostics Lung Cancer Diagnostics Product Offered
Table 95. BioMark Diagnostics Main Business
Table 96. BioMark Diagnostics Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. BioMark Diagnostics Latest Developments
Table 98. Mayo Clinic Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 99. Mayo Clinic Lung Cancer Diagnostics Product Offered
Table 100. Mayo Clinic Main Business
Table 101. Mayo Clinic Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Mayo Clinic Latest Developments
Table 103. HalioDx SAS Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 104. HalioDx SAS Lung Cancer Diagnostics Product Offered
Table 105. HalioDx SAS Main Business
Table 106. HalioDx SAS Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. HalioDx SAS Latest Developments
Table 1. Lung Cancer Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immunoassays
Table 3. Major Players of Flow Cytometry
Table 4. Major Players of Rapid Tests
Table 5. Major Players of Molecular Assays
Table 6. Major Players of Tissue Arrays
Table 7. Major Players of Circulating Tumor Cells
Table 8. Major Players of Pharmacodiagnostics
Table 9. Major Players of Biomarkers
Table 10. Major Players of Other
Table 11. Lung Cancer Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 13. Global Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 14. Lung Cancer Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 15. Global Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 16. Global Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 17. Global Lung Cancer Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 18. Global Lung Cancer Diagnostics Revenue Market Share by Player (2019-2024)
Table 19. Lung Cancer Diagnostics Key Players Head office and Products Offered
Table 20. Lung Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Lung Cancer Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 24. Global Lung Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Table 25. Global Lung Cancer Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Lung Cancer Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Lung Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 28. Americas Lung Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 29. Americas Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. Americas Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. Americas Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. Americas Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. APAC Lung Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 34. APAC Lung Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 35. APAC Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. APAC Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. APAC Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. APAC Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Europe Lung Cancer Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 40. Europe Lung Cancer Diagnostics Market Size Market Share by Country (2019-2024)
Table 41. Europe Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Europe Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Europe Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Europe Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Middle East & Africa Lung Cancer Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Table 47. Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Table 49. Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 50. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Table 51. Key Market Drivers & Growth Opportunities of Lung Cancer Diagnostics
Table 52. Key Market Challenges & Risks of Lung Cancer Diagnostics
Table 53. Key Industry Trends of Lung Cancer Diagnostics
Table 54. Global Lung Cancer Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 55. Global Lung Cancer Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 56. Global Lung Cancer Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 57. Global Lung Cancer Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 58. Roche Diagnostics Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 59. Roche Diagnostics Lung Cancer Diagnostics Product Offered
Table 60. Roche Diagnostics Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Roche Diagnostics Main Business
Table 62. Roche Diagnostics Latest Developments
Table 63. BioMйrieux Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 64. BioMйrieux Lung Cancer Diagnostics Product Offered
Table 65. BioMйrieux Main Business
Table 66. BioMйrieux Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. BioMйrieux Latest Developments
Table 68. Qiagen Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 69. Qiagen Lung Cancer Diagnostics Product Offered
Table 70. Qiagen Main Business
Table 71. Qiagen Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Qiagen Latest Developments
Table 73. Advpharma Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 74. Advpharma Lung Cancer Diagnostics Product Offered
Table 75. Advpharma Main Business
Table 76. Advpharma Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Advpharma Latest Developments
Table 78. AIT Austrian Institute of Technology Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 79. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Offered
Table 80. AIT Austrian Institute of Technology Main Business
Table 81. AIT Austrian Institute of Technology Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. AIT Austrian Institute of Technology Latest Developments
Table 83. Courtagen Life Sciences Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 84. Courtagen Life Sciences Lung Cancer Diagnostics Product Offered
Table 85. Courtagen Life Sciences Main Business
Table 86. Courtagen Life Sciences Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Courtagen Life Sciences Latest Developments
Table 88. DiagnoCure Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 89. DiagnoCure Lung Cancer Diagnostics Product Offered
Table 90. DiagnoCure Main Business
Table 91. DiagnoCure Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. DiagnoCure Latest Developments
Table 93. BioMark Diagnostics Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 94. BioMark Diagnostics Lung Cancer Diagnostics Product Offered
Table 95. BioMark Diagnostics Main Business
Table 96. BioMark Diagnostics Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. BioMark Diagnostics Latest Developments
Table 98. Mayo Clinic Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 99. Mayo Clinic Lung Cancer Diagnostics Product Offered
Table 100. Mayo Clinic Main Business
Table 101. Mayo Clinic Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Mayo Clinic Latest Developments
Table 103. HalioDx SAS Details, Company Type, Lung Cancer Diagnostics Area Served and Its Competitors
Table 104. HalioDx SAS Lung Cancer Diagnostics Product Offered
Table 105. HalioDx SAS Main Business
Table 106. HalioDx SAS Lung Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. HalioDx SAS Latest Developments
LIST OF FIGURES
Figure 1. Lung Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Cancer Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Lung Cancer Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Lung Cancer Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Lung Cancer Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Lung Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 10. Lung Cancer Diagnostics in Industrial
Figure 11. Global Lung Cancer Diagnostics Market: Industrial (2019-2024) & ($ Millions)
Figure 12. Lung Cancer Diagnostics in Healthcare
Figure 13. Global Lung Cancer Diagnostics Market: Healthcare (2019-2024) & ($ Millions)
Figure 14. Lung Cancer Diagnostics in Other
Figure 15. Global Lung Cancer Diagnostics Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Lung Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Lung Cancer Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Lung Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Lung Cancer Diagnostics Value Market Share by Country in 2023
Figure 24. United States Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Lung Cancer Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Lung Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC Lung Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 31. China Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Lung Cancer Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global Lung Cancer Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Lung Cancer Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Lung Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Cancer Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Lung Cancer Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Lung Cancer Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Lung Cancer Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Lung Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 10. Lung Cancer Diagnostics in Industrial
Figure 11. Global Lung Cancer Diagnostics Market: Industrial (2019-2024) & ($ Millions)
Figure 12. Lung Cancer Diagnostics in Healthcare
Figure 13. Global Lung Cancer Diagnostics Market: Healthcare (2019-2024) & ($ Millions)
Figure 14. Lung Cancer Diagnostics in Other
Figure 15. Global Lung Cancer Diagnostics Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Lung Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global Lung Cancer Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global Lung Cancer Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Lung Cancer Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Lung Cancer Diagnostics Value Market Share by Country in 2023
Figure 24. United States Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Lung Cancer Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC Lung Cancer Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC Lung Cancer Diagnostics Market Size Market Share by Application in 2023
Figure 31. China Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Lung Cancer Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Lung Cancer Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Lung Cancer Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Lung Cancer Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global Lung Cancer Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Lung Cancer Diagnostics Market Size Market Share Forecast by Application (2025-2030)
